GrowGeneration Provides Fourth Quarter and Full Year Updated Outlook with Record 2021 Annual Revenues Full year revenue estimated between $420 million to $422 million, an increase of 118% over prior year Same-store-sales up 24.4% for full year 2021 DENVER, Jan. 13, 2022 /PRNewswire/ – GrowGeneration Corp. (NASDAQ: GRWG), (“GrowGen” or... Read more
Exclusive Interview with The Valens Company CEO and Chair of the Board Tyler Robson The Valens Company (TSX: VLNS) (NASDAQ: VLNS) CEO and Chair of the Board Tyler Robson last checked in with New Cannabis Ventures in April 2021. Since then, the cannabis manufacturing company has made a number... Read more
NeonMind Appoints Canadian Medical Leader In Anesthesiology, Dr. Daniel Bainbridge, MD, FRCPC To Its Specialty Clinics Advisory Board
Ryan Allway January 13th, 2022 Psychedelics Dr. Bainbridge’s Expertise and Network Provides Safety Best-Practices for Administration of Intravenous Ketamine (IV-Ketamine) at NeonMind Clinics Vancouver, B.C. – January 13, 2022: NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FRA: 6UF) (“NeonMind” or the “Company”), an integrated drug development and wellness company, announced... Read more
Auxly Maintains Top Position in 2.0, Dominates Vape Sales and Grows National Market Share Through 1.0 Expansion in 2021
Ryan Allway January 13th, 2022 Headset data confirms Auxly almost doubled overall market share, ending the year as the #5 LP in Canada and continues to hold the #1 LP position in National Cannabis 2.0 salesi TORONTO, Jan. 13, 2022 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX –... Read more
PODA Granted US Patent for Closed Bottom Vaporizer Pod
Ryan Allway January 13th, 2022 News, Top News VANCOUVER, BC , Jan. 13, 2022 /CNW/ – PODA HOLDINGS, INC. (“Poda” or the “Company”) (CSE: PODA) (FSE: 99L) (OTCQB: PODAF) is pleased to announce that it has been granted a US Patent by the US Patent and Trademark Office concerning US Application 16/340,058 for Poda’s Closed... Read more
atai Life Sciences announces FDA Investigational New Drug (IND) Clearance for PCN-101 R-ketamine Program

atai Life Sciences announces Investigational New Drug (IND) clearance from the FDA for PCN-101.

Read more
Psychedelics Convergence in 2022: Crisis Meets Opportunity

The Mental Health Crisis spirals. Psychedelic medicine advances. In 2022, “crisis” meets “opportunity”.

Read more
Waitr Acquires Software Company Cova in Pivot Toward Cannabis Delivery
Waitr Holdings Inc. (Nasdaq: WTRH) has entered into a non-binding letter of intent to acquire Retail Innovation Labs Inc., a leading point of sale, inventory and compliance software business serving cannabis dispensary retailers in North America. Waitr’s acquisition of Retail Innovation Labs, which does business as Cova, represents the... Read more
The Valens Company CEO Tyler Robson on Creating a One-Stop-Shop for Cannabis
The Valens Company (NASDAQ/TSX: VLNS) is a Kelowna, BC-based cannabis multi-state company with a very distinctive structure and objective. At first glance, it may look like just another extraction company but look again and its shape shifts into that of a global distributor and then again into a creator... Read more
Virginia made history last year when it became the first state in the South to fully legalize cannabis, but a new governor and a reenactment clause in the law could bring changes to the original statute that the General Assembly approved in April. “Virginia’s legalization law … was somewhat... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )